首页> 外文期刊>Theranostics >A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation
【24h】

A Biomimetic Gold Nanocages-Based Nanoplatform for Efficient Tumor Ablation and Reduced Inflammation

机译:基于仿生金纳米笼的纳米平台,可有效消融肿瘤并减少炎症

获取原文
       

摘要

Gold nanocages (AuNCs), with high photothermal conversion efficiency and unique hollow interiors, have become a promising nanoplatform for synergistic phototheraml therapy (PTT)-chemotherapy. However, the insufficient tumor targeting, in vivo premature drug leakage and low drug loading efficiency responsible for the spatial-temporal un-synchronization of PTT-chemotherapy, as well as inflammatory response might compromise the anticancer treatment of AuNCs-based drug delivery systems. Methods: Cancer cell membrane (CCM)-coated AuNCs were developed to load anticancer drug doxorubicin (DOX@CAuNCs) by transmembrane ammonium sulfate gradient method. In vitro and in vivo analysis, including characterization, macrophage phagocytosis and tumor targeting capacity, near-infrared (NIR) laser-induced drug release, antitumor efficacy and inflammation response were systematically performed. Results: DOX@CAuNCs showed a high DOX loading capacity and on-demand NIR laser-triggered DOX release compared with CAuNCs passively loading DOX by electrostatic adsorption, a commonly used method to load drug to AuNCs. Meanwhile, in view of the properties of CCM coated on AuNCs, DOX@CAuNCs exhibited decreased macrophage phagocytosis, prolonged blood circulation and enhanced internalization by cancer cells, generating preferable tumor targeting ability. With these integrated advantages, DOX@CAuNCs demonstrated highly efficient and precise spatial-temporal synchronization of PTT-chemotherapy, achieving complete tumor ablation with no obvious side effects. Besides, coating with CCM significantly alleviated AuNCs-induced inflammatory response. Conclusion: This biomimetic AuNCs-based platform might be a prospective drug delivery system for precision PTT and chemotherapy, acquiring desired cancer treatment efficacy and low inflammatory response.
机译:金纳米笼(AuNCs)具有高的光热转换效率和独特的中空内部结构,已成为协同光疗(PTT)-化学疗法的有前途的纳米平台。然而,肿瘤靶向不足,体内过早药物泄漏和药物装载效率低是造成PTT化疗时空不同步以及炎症反应的原因,可能会损害基于AuNCs的药物递送系统的抗癌治疗。方法:采用跨膜硫酸铵梯度法开发了包有癌细胞膜(CCM)的AuNCs,以加载抗癌药阿霉素(DOX @ CAuNCs)。系统地进行了体外和体内分析,包括表征,巨噬细胞吞噬作用和肿瘤靶向能力,近红外(NIR)激光诱导的药物释放,抗肿瘤功效和炎症反应。结果:与CAuNCs通过静电吸附被动装载DOX相比,DOX @ CAuNCs具有较高的DOX装载能力和按需NIR激光触发的DOX释放,而CAuNCs是通过静电吸附将药物装载到AuNCs的常用方法。同时,考虑到包被在AuNCs上的CCM的特性,DOX @ CAuNCs表现出减少的巨噬细胞吞噬作用,延长的血液循环和增强的癌细胞内在化作用,产生了较好的肿瘤靶向能力。凭借这些综合优势,DOX @ CAuNCs展示了PTT化学疗法的高效且精确的时空同步,实现了完整的肿瘤消融,而没有明显的副作用。此外,用CCM涂层可显着减轻AuNCs引起的炎症反应。结论:基于仿人AuNCs的仿生平台可能是用于精确PTT和化学疗法的前瞻性药物递送系统,可获得所需的癌症治疗效果和较低的炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号